July 2024 THE RELATIONSHIP BETWEEN TESTOSTERONE AND PROSTATE CANCER, TRT AND MOREIn this episode of "The Drive with Peter Attia, M.D.," Edward M. Schaeffer, MD, PhD, Chair of the Department of Urology, delves into the complex role of testosterone in prostate cancer, shedding light on the TRAVERSE trial's insights and the androgen receptor saturation theory. He discusses the Decipher test for assessing cancer aggressiveness and offers guidance on safely administering testosterone replacement therapy to men with low-grade prostate cancer. Dr. Schaeffer also highlights recent advancements in prostate cancer therapies and biomarkers that enable more targeted and precise treatment strategies, reducing the need for broad androgen deprivation therapy.
|
Edward M. Schaeffer, MD, PhD, Chair of Urology and the Harold Binstein Professor of Urology at Northwestern Medicine
Refer a PatientNorthwestern Medicine welcomes the opportunity to partner with you in caring for your patients.
|